Effectiveness of Galcanezumab and Traditional Oral Migraine Preventive Medications: Interim 3-Month Japan Subgroup Findings from the TRIUMPH Study.

Emgality (galcanezumab-gnlm) - Eli Lilly, Daiichi Sankyo

http://www.ncbi.nlm.nih.gov/pubmed/42018233

Chie Hashimoto; Daisuke Danno; Hideaki Katagiri; Kaname Ueda; Takao Takeshima; Tsubasa Takizawa; Yasuhiko Matsumori; Zhihong Cai

Apr 22, 2026